-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E5rQJc7fIMfGNwBxIewN9azNMu+8MnjhUDHRd+wp0Y9dcCPmyxyE8iJn5d9YxJE4 /i/+rFmWJMsTkcFKQ8stkg== 0000930413-08-006719.txt : 20081114 0000930413-08-006719.hdr.sgml : 20081114 20081114181921 ACCESSION NUMBER: 0000930413-08-006719 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081113 FILED AS OF DATE: 20081114 DATE AS OF CHANGE: 20081114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SALISBURY ROBERT C CENTRAL INDEX KEY: 0001185468 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 081193459 BUSINESS ADDRESS: STREET 1: 865 S W 75TH AVENUE STREET 2: SUITE 100 CITY: PLANTATION STATE: FL ZIP: 33324 BUSINESS PHONE: 9542338746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4/A 1 c55681_ex.xml X0303 4/A 2008-11-13 2008-11-14 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001185468 SALISBURY ROBERT C C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807 1 0 0 0 Common Stock 2008-11-13 4 P 0 2873 3.19 A 28034 D Common Stock 2008-11-13 4 P 0 600 3.20 A 28634 D Common Stock 2008-11-13 4 P 0 1897 3.21 A 30531 D Common Stock 2008-11-13 4 P 0 500 3.23 A 31031 D Common Stock 2008-11-13 4 P 0 100 3.24 A 31131 D Common Stock 2008-11-13 4 P 0 4030 3.25 A 35161 D The Reporting Person's Form 4 filed with the SEC earlier today, November 14, 2008, incorrectly indicated that the Reporting Person disposed (D) of 4,030 shares of Common Stock at $3.25 per share. This Form 4 Amendment is being filed to correct such clerical error. The correct entry, an acquisition (A) of 4,030 shares of Common Stock at $3.25 per share, is set forth above along with a restatement of the Reporting Person's other acquisitions of Common Stock on November 13, 2008. /s/ Craig A. Tooman, Attorney-In-Fact 2008-11-14 -----END PRIVACY-ENHANCED MESSAGE-----